Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a hand-held portable coagulation analyzer. The Xprecia Stride Coagulation Analyzer delivers fast, reliable Prothrombin Time International Normalized Ratio (PT/INR) testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist.

Millions of PT/INR tests are administered world-wide each year as part of therapy monitoring for patients with a host of conditions, including atrial fibrillation, heart valve replacement surgery, deep vein thrombosis and congenital heart defects, among others. The Xprecia Stride Coagulation Analyzer was specifically designed to meet the growing demand for fast and reliable PT/INR results in physician offices and walk-in clinics to help healthcare professionals make informed decisions about patient care.

Winner of multiple international design awards such as the Red Dot Award: Product Design for 2015 and the iFDesign Award, the analyzer includes a number of innovations and features not found on most other point-of-care analyzers. No bigger than a smartphone and weighing just 10.5 oz, the Xprecia Stride Coagulation Analyzer can be held at virtually any angle and brought directly to the patient’s finger for efficient and comfortable blood sample application.

“Among the many challenges of point of care testing, accuracy and safety have become paramount to both the user and patient. With the Xprecia Stride analyzer, Siemens Healthineers delivers on the promise to bring a safe and lab-accurate test directly to the patient,” said Michael Sampson, Senior Vice President, Point of Care, Siemens Healthineers, North America. “The Xprecia Stride analyzer is designed to be safe, efficient and ergonomically friendly. By adding the Xprecia Stride analyzer to our existing product portfolio in the U.S., we now have the ability to cover the full range of hemostasis testing from the hospital lab to the physician’s office.”

Today’s busy healthcare professional is challenged by a complex work environment and heavy patient workflow. The Xprecia Stride analyzer was designed to address these concerns through an intuitive user interface and features such as an integrated barcode scanner to simplify data capture and improve patient workflow. To further enhance usability, the Xprecia Stride features simple icons and animation in a color display more commonly found in mobile devices than medical instruments.

The Xprecia Stride analyzer uses fresh capillary (fingerstick) whole blood and results are expressed as INR. It utilizes the same Dade® Innovin® reagent used by Siemens Healthineers central lab analyzers to minimize any potential for variability. Studies have shown the performance to be equivalent to a reference laboratory hemostasis system, with results available within minutes.

Safety features include a first-of-its kind test strip eject button that allows the user to eject a used test strip and easily dispose of it without touching it, minimizing potential biohazard exposure.

When taken together, all of these innovations ultimately enable better patient care as point-of-care PT/INR testing becomes critical to healthcare providers managing the growing number of patients that require anticoagulation therapy.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Siemens Healthineers Point of Care Diagnostics. (2023, June 02). Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer. News-Medical. Retrieved on November 08, 2024 from https://www.news-medical.net/news/20161006/Siemens-announces-FDA-510(k)-clearance-for-Xprecia-Stride-Coagulation-Analyzer.aspx.

  • MLA

    Siemens Healthineers Point of Care Diagnostics. "Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer". News-Medical. 08 November 2024. <https://www.news-medical.net/news/20161006/Siemens-announces-FDA-510(k)-clearance-for-Xprecia-Stride-Coagulation-Analyzer.aspx>.

  • Chicago

    Siemens Healthineers Point of Care Diagnostics. "Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer". News-Medical. https://www.news-medical.net/news/20161006/Siemens-announces-FDA-510(k)-clearance-for-Xprecia-Stride-Coagulation-Analyzer.aspx. (accessed November 08, 2024).

  • Harvard

    Siemens Healthineers Point of Care Diagnostics. 2023. Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer. News-Medical, viewed 08 November 2024, https://www.news-medical.net/news/20161006/Siemens-announces-FDA-510(k)-clearance-for-Xprecia-Stride-Coagulation-Analyzer.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Siemens Healthineers to expand SARS-CoV-2 testing to include a total antibody test to aid in the COVID-19 pandemic